RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund I Cap CHF/ LU1120849671 /
| NAV01.10.2024 | Diff.-0.1900 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
|---|---|---|---|---|
| 91.0100CHF | -0.21% | thesaurierend | Aktien weltweit | FundPartner Sol.(EU) ▶ |
Monatliche Performance
| Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez | Gesamt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 4.24 | -4.03 | -5.75 | 2.46 | -1.14 | 5.64 | -2.48 | 3.04 | -4.81 | -0.72 | -5.75 | 2.19 | -7.71% |
| 2022 | -8.93 | -2.22 | 3.21 | -8.15 | -0.80 | 0.65 | 2.61 | -2.58 | -4.48 | 8.48 | 6.52 | -1.81 | -8.70% |
| 2023 | 3.80 | -6.78 | 0.09 | -2.33 | -0.44 | -1.29 | 2.44 | -1.60 | -5.53 | -8.57 | 5.39 | 9.29 | -6.76% |
| 2024 | -3.19 | 0.91 | 2.13 | -5.36 | 2.68 | 4.58 | 4.75 | 2.70 | -2.64 | -0.21 | - | - | - |
Kennzahlen
| lfd. Jahr | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|
| Volatilität | 13.92% | 13.99% | 15.49% | 20.06% | -% |
| Sharpe Ratio | 0.35 | 0.75 | 0.60 | -0.39 | - |
| Bester Monat | +9.29% | +4.75% | +9.29% | +9.29% | - |
| Schlechtester Monat | -5.36% | -5.36% | -8.57% | -8.93% | - |
| Maximaler Verlust | -9.88% | -7.68% | -9.88% | -30.41% | - |
| Outperformance | - | - | - | - | - |
Alle Kurse in CHF
Tranchen
| Titel | Ertragstyp | Rückn. Preis | 1 Jahr | 3 Jahre | |
|---|---|---|---|---|---|
| RH&P Glob. Life Sciences Fd. I c... | ausschüttend | 97.6400 | +15.26% | -9.41% | |
| RH&PARTNER Investment Funds SICA... | thesaurierend | 91.0100 | +12.51% | -13.08% | |
| RH&PARTNER Investment Funds SICA... | thesaurierend | 182.3900 | +16.73% | -5.06% |
Performance
| lfd. Jahr | +5.99% | ||
|---|---|---|---|
| 6 Monate | +6.68% | ||
| 1 Jahr | +12.51% | ||
| 3 Jahre | -13.08% | ||
| 5 Jahre | - | ||
| 10 Jahre | - | ||
| seit Beginn | -16.73% | ||
| Jahr | |||
| 2023 | -6.76% | ||
| 2022 | -8.70% | ||
| 2021 | -7.71% | ||
